Viyash Scientific · NSE: VIYASH · BSE: 512529
Q4 FY20 results · Jan–Mar 2020
Viyash Scientific reported revenue from operations of ₹300.58 crore (up 6.6% from Q4 FY19) and net profit of ₹18.23 crore (down 14.5% from Q4 FY19) for Q4 FY20 (Jan–Mar 2020), on a consolidated basis.
| Item | Q4 FY20 | Q4 FY19 | YoY | Q3 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 300.58 | 281.90 | +6.6% | 316.42 | −5.0% |
| Other income | 1.82 | 2.43 | −24.8% | 0.98 | +85.8% |
| Total income | 302.41 | 284.33 | +6.4% | 317.40 | −4.7% |
| Profit before tax | 24.14 | 21.60 | +11.7% | 28.31 | −14.7% |
| Net profit for the period | 18.23 | 21.33 | −14.5% | 24.06 | −24.2% |
| Attributable to shareholders of the company | 16.86 | 17.12 | −1.6% | 20.30 | −17.0% |
| EPS, basic (₹) | 0.69 | 0.71 | −2.8% | 0.83 | −16.9% |
| Net margin (%) | 6.1 | 7.6 | 7.6 |
| Item | Q4 FY20 | Q4 FY19 | YoY | Q3 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 62.29 | 57.01 | +9.3% | 61.80 | +0.8% |
| Other income | 3.05 | 1.58 | +93.4% | 2.11 | +44.4% |
| Total income | 65.35 | 58.59 | +11.5% | 63.91 | +2.2% |
| Profit before tax | 10.06 | 0.01 | 2011x | 4.69 | +114.3% |
| Net profit for the period | 6.82 | 1.39 | +390.9% | 2.92 | +133.6% |
| EPS, basic (₹) | 0.28 | 0.06 | +366.7% | 0.12 | +133.3% |
| Net margin (%) | 10.9 | 2.4 | 4.7 |
Consolidated
- Filed with BSE
- 13 May 2020, 16:44 IST
- Board meeting
- 12 May 2020
- Period
- 01 Jan 2020 to 31 Mar 2020
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 13 May 2020, 16:44 IST
- Board meeting
- 12 May 2020
- Period
- 01 Jan 2020 to 31 Mar 2020
- Review status
- Audited
- Source
- XBRL filing on BSE